Abiopharma

🔍 Liu Xiaozhi (Executive)

Company: AUTOLIV INC (ALV)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 1,756 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: false | shares_owned_after: 16,983.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 263 shares of Common Stock at $121.01 per share (Direct)
  Date: 2026-05-07 | Code: F | equity_swap_involved: false | shares_owned_after: 16,720.00 | transaction_form_type: 4
• Sold 1,756 shares of Restricted Stock Unit (Derivative)
  Date: 2026-05-07 | Code: M | Expires: 2026-05-07 | Exercise: 2026-05-07 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F1, F3
• Acquired 1,405 shares of Restricted Stock Unit (Derivative)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 1,405.00 | transaction_form_type: 4 | Footnotes: F2, F4, F5, F5

Footnotes:

• F1: Reflects the vesting of restricted stock units (RSUs) granted on May 8, 2025 as part of the 2025-2026 annual retainer for non-employee director service.
• F2: Each RSU represents a contingent right to receive one share of ALV common stock.
• F3: Fractional RSUs are rounded down to the nearest whole number at vesting, the fractional amount is forfeited.
• F4: Reflects a grant of RSUs as part of the 2026-2027 annual retainer for non-employee director service.
• F5: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026.